More Than Numbers: The Power of Graphs in Meta-analysis
In meta-analysis, the assessment of graphs is widely used in an attempt to identify or…
CertaraJanuary 15, 2009
Pharmacokinetic Predictions in Children by Using the Physiologically-based Pharmacokinetic Modeling
Nowadays, 50-90% of drugs used in children have never been actually studied in this population. Consequently, either…
CertaraDecember 1, 2008
Covariation of Human Microsomal Protein per Gram of Liver with Age: Absence of Influence of Operator and Sample Storage May Justify Interlaboratory Data Pooling
Scaling of metabolic clearance values from liver microsomal data or recombinantly expressed cytochrome P450 enzymes…
CertaraDecember 1, 2008
Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon-like Peptide-2 (GLP-2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects
Teduglutide, a glucagon-like peptide-2 (GLP-2) analog, is currently being evaluated for the treatment of short-bowel…
CertaraNovember 1, 2008
Maraviroc: In Vitro Assessment of Drug-drug Interaction Potential
AIMS: To characterize the cytochrome P450 enzyme(s) responsible for the N-dealkylation of maraviroc in vitro,…
CertaraOctober 1, 2008
Meta-analysis of the Diagnostic Accuracy of Transesophageal Echocardiography for Assessment of Atherosclerosis in the Ascending Aorta in Patients Undergoing Cardiac Surgery
Stroke after cardiac surgery may be caused by emboli emerging from an atherosclerotic ascending aorta…
CertaraOctober 1, 2008
Accurate and Interpretable Computational Modeling of Chemical Mutagenicity
We describe a method for modeling chemical mutagenicity in terms of simple rules based on…
CertaraSeptember 5, 2008
Integrating Systems Approaches into Pharmaceutical Sciences
During the first week of December 2007, the European Federation for Pharmaceutical Sciences (EUFEPS) and…
CertaraSeptember 2, 2008
Bioavailability and Bioequivalence: Focus on Physiological Factors and Variability
This is a summary report of the EUFEPS & COST B25 conference on Bioavailability and…
CertaraAugust 1, 2008
A Novel Druglike Spleen Tyrosine Kinase Binder Prevents Anaphylactic Shock when Administered Orally
BACKGROUND: The spleen tyrosine kinase (Syk) is recognized as a potential pharmaceutical target for the…
CertaraJuly 1, 2008
